Team:DTU-Denmark-2/Our Partners/Sponsors
From 2011.igem.org
(Difference between revisions)
Line 23: | Line 23: | ||
<td width="100%" height="100%" valign="top" > | <td width="100%" height="100%" valign="top" > | ||
- | <a href="http://www.novozymes.com" target="_blank"> <img src="https://static.igem.org/mediawiki/2011/a/a2/Novozymes.jpeg" with="150px"height="150px" alt=""" class="centered"/> </a> | + | <a href="http://www.novozymes.com" target="_blank"> <img src="https://static.igem.org/mediawiki/2011/a/a2/Novozymes.jpeg" with="150px"height="150px" alt=""" class="centered"/> </a><br> |
- | + | ||
<p align="justify"> | <p align="justify"> | ||
- | Novozymes is one of the world's leading companies within the field of enzyme discovery and biotechnology. Novozymes is based on bioinnovation | + | Novozymes is one of the world's leading companies within the field of enzyme discovery and biotechnology. Novozymes is based on bioinnovation and their core business is industrial enzymes, microorganisms and biopharmaceutical ingredients. Novozymes has made it possible for the team to participate in iGEM 2011 through financial support. |
- | Novozymes has made it possible for the team to participate in iGEM 2011 through financial support. | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</p> | </p> | ||
</td> | </td> | ||
<td width="100%" height="100%" valign="top"> | <td width="100%" height="100%" valign="top"> | ||
- | |||
<a href="http://www.bavarian-nordic.com/" target="_blank"> <img src="https://static.igem.org/mediawiki/2011/5/5c/Bn_logo_rgb.jpg" with="240px"height="240px" alt=""" class="centered"/> </a> | <a href="http://www.bavarian-nordic.com/" target="_blank"> <img src="https://static.igem.org/mediawiki/2011/5/5c/Bn_logo_rgb.jpg" with="240px"height="240px" alt=""" class="centered"/> </a> | ||
<p align="justify"> | <p align="justify"> | ||
- | Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases. Bavarian Nordic focuses on cancer, biodefence and infectious deceases as HIV and RSV. | + | Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases. Bavarian Nordic focuses on cancer, biodefence and infectious deceases as HIV and RSV. Bavarian Nordic have contributed to the team with financial support. |
</p> | </p> | ||
</td> | </td> | ||
Line 53: | Line 46: | ||
<a href="http://www.alk-abello.com" target="_blank"><img src="https://static.igem.org/mediawiki/2011/0/0c/Alk_Logo.jpg" with="80px"height="80px"alt=""" class="centered"/> </a> | <a href="http://www.alk-abello.com" target="_blank"><img src="https://static.igem.org/mediawiki/2011/0/0c/Alk_Logo.jpg" with="80px"height="80px"alt=""" class="centered"/> </a> | ||
<p align="justify"> | <p align="justify"> | ||
- | ALK | + | ALK Abello develops allergy products for the diagnosis, prevention and cure of allergies. They develop pharmaceutical products that target the actual cause of allergy and have a treatments, which is recognized by WHO as the only treatment that can change the underlying allergic disease. ALK abello have made are experimental work possible. |
- | + | ||
</p> | </p> | ||
Revision as of 16:48, 20 September 2011
Sponsors